Hutchmed China gets conditional NMPA approval for ATLED in China
Hutchmed (China) announced NMPA conditional approval for ATLED in China.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Hutchmed (China) gets NMPA conditional approval for Atled in China
Hutchmed (China) announced NMPA conditional approval for Atled (fantegratinib) in China.